Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Profit After Tax: 2012-2024

Historic Profit After Tax for BioLineRx (BLRX) over the last 13 years, with Dec 2024 value amounting to -$9.2 million.

  • BioLineRx's Profit After Tax changed negligibly% to -$1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$3.5 million, marking a year-over-year increase of 81.96%. This contributed to the annual value of -$9.2 million for FY2024, which is 84.79% up from last year.
  • Per BioLineRx's latest filing, its Profit After Tax stood at -$9.2 million for FY2024, which was up 84.79% from -$60.6 million recorded in FY2023.
  • In the past 5 years, BioLineRx's Profit After Tax ranged from a high of -$9.2 million in FY2024 and a low of -$60.6 million during FY2023.
  • In the last 3 years, BioLineRx's Profit After Tax had a median value of -$25.0 million in 2022 and averaged -$31.6 million.
  • Per our database at Business Quant, BioLineRx's Profit After Tax slumped by 142.93% in 2023 and then surged by 84.79% in 2024.
  • Over the past 5 years, BioLineRx's Profit After Tax (Yearly) stood at -$30.0 million in 2020, then climbed by 9.88% to -$27.1 million in 2021, then increased by 7.77% to -$25.0 million in 2022, then plummeted by 142.93% to -$60.6 million in 2023, then skyrocketed by 84.79% to -$9.2 million in 2024.